Covid-19 phase 3 trial of lenzilumab : Humanigen announces positive interim results
Humanigen said that lenzilumab has delivered a clinically meaningful impact on the recovery of patients hospitalized with Covid-19, as per the interim data of a phase 3 trial. According to the US biopharma company, the interim analysis for sizing and powering, an estimated 37% more recoveries were seen in the lenzilumab arm of the randomized, […]